(Q41488117)

1 October 2017

0 references

Medical therapy for nonalcoholic fatty liver disease in children and adolescents (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

1 October 2017

1 reference

1 reference

2

Joel E Lavine

1 reference

1 October 2017

Danielle B Andrews

1

1 reference

1 October 2017

1 February 2012

1 reference

Expert Review of Gastroenterology & Hepatology

1 October 2017

1 reference

1 October 2017

6

1 reference

1 October 2017

1

1 reference

1 October 2017

1-3

1 reference

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285489

Endpoints and clinical trial design for nonalcoholic steatohepatitis

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285489

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285489

Treatment of nonalcoholic fatty liver disease in children: TONIC trial design

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285489

Advances in pediatric nonalcoholic fatty liver disease

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285489

The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285489

Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285489

Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285489

Prevalence of fatty liver in children and adolescents.

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285489

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285489

A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis.

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285489

Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285489

Steatohepatitis: a tale of two "hits"?

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285489

Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease.

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285489

Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285489

Histopathology of pediatric nonalcoholic fatty liver disease.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285489

19 August 2018

Identifiers

DOI

10.1586/EGH.11.72

1 reference

1 October 2017

1 reference

PMC publication ID

3285489

1 October 2017

PubMed publication ID

22149573

1 reference

PMC publication ID

3285489